{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:38:13Z","timestamp":1789695493254,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.steroids.2022.109063","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T11:08:31Z","timestamp":1654945711000},"page":"109063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["MiR-221-5p\/Smad3 axis in osteoclastogenesis and its function: Potential therapeutic target for osteoporosis"],"prefix":"10.1016","volume":"185","author":[{"given":"Min","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanjun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.steroids.2022.109063_b0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ecl.2016.11.001","article-title":"Novel therapies for postmenopausal osteoporosis","volume":"46","author":"Bandeira","year":"2017","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"3","key":"10.1016\/j.steroids.2022.109063_b0010","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical practice. Postmenopausal osteoporosis","volume":"374","author":"Solomon","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.steroids.2022.109063_b0015","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/BOR.0000000000000509","article-title":"Long-term treatment strategies for postmenopausal osteoporosis","volume":"30","author":"Cosman","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.steroids.2022.109063_b0020","doi-asserted-by":"crossref","first-page":"16069","DOI":"10.1038\/nrdp.2016.69","article-title":"Postmenopausal osteoporosis","volume":"2","author":"Eastell","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.steroids.2022.109063_b0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s11658-019-0146-0","article-title":"MiR-125a-5p promotes osteoclastogenesis by targeting TNFRSF1B","volume":"24","author":"Sun","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"5","key":"10.1016\/j.steroids.2022.109063_b0030","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/ar4282","article-title":"miR-31 controls osteoclast formation and bone resorption by targeting RhoA","volume":"15","author":"Mizoguchi","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.steroids.2022.109063_b0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/abbs\/gmy006","article-title":"MiRNA-133a is involved in the regulation of postmenopausal osteoporosis through promoting osteoclast differentiation","volume":"50","author":"Li","year":"2018","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"4","key":"10.1016\/j.steroids.2022.109063_b0040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/rej.2019.2239","article-title":"MiR-151a-3p promotes postmenopausal osteoporosis by targeting SOCS5 and activating JAK2\/STAT3 signaling","volume":"23","author":"Fu","year":"2020","journal-title":"Rejuvenation Res."},{"issue":"18","key":"10.1016\/j.steroids.2022.109063_b0045","first-page":"7766","article-title":"MiRNA-365a-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation via targeting RUNX2","volume":"23","author":"Cheng","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.steroids.2022.109063_b0050","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2147\/OTT.S232953","article-title":"Promotion of miR-221-5p on the sensitivity of gastric cancer cells to cisplatin and its effects on cell proliferation and apoptosis by regulating DDR1","volume":"13","author":"Jiang","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.steroids.2022.109063_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109406","article-title":"miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer","volume":"119","author":"Liu","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.steroids.2022.109063_b0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12894-018-0325-8","article-title":"miR-221-5p enhances cell proliferation and metastasis through post-transcriptional regulation of SOCS1 in human prostate cancer","volume":"18","author":"Shao","year":"2018","journal-title":"BMC Urol"},{"issue":"6","key":"10.1016\/j.steroids.2022.109063_b0065","first-page":"6536","article-title":"Inhibition of microRNA-221-5p induces osteogenic differentiation by directly targeting smad3 in myeloma bone disease mesenchymal stem cells","volume":"18","author":"Fan","year":"2019","journal-title":"Oncol. Lett."},{"issue":"9","key":"10.1016\/j.steroids.2022.109063_b0070","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.tcb.2017.04.005","article-title":"Transforming growth factor-beta receptors and Smads: regulatory complexity and functional versatility","volume":"27","author":"Budi","year":"2017","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.steroids.2022.109063_b0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.lfs.2018.03.042","article-title":"Overexpressed miR-145 inhibits osteoclastogenesis in RANKL-induced bone marrow-derived macrophages and ovariectomized mice by regulation of Smad3","volume":"202","author":"Yu","year":"2018","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.steroids.2022.109063_b0080","doi-asserted-by":"crossref","first-page":"9724","DOI":"10.1002\/jcp.26914","article-title":"Small molecule inhibitor RepSox prevented ovariectomy-induced osteoporosis by suppressing osteoclast differentiation and bone resorption","volume":"233","author":"Mei","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.steroids.2022.109063_b0085","doi-asserted-by":"crossref","first-page":"14570","DOI":"10.1038\/ncomms14570","article-title":"SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts","volume":"8","author":"Xu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.steroids.2022.109063_b0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fcvm.2019.00056","article-title":"Olive leaf extract attenuates inflammatory activation and DNA damage in human arterial endothelial cells","volume":"6","author":"Burja","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.steroids.2022.109063_b0095","first-page":"462","article-title":"Description of a new method of ovariectomy in female rats","volume":"52","author":"Khajuria","year":"2012","journal-title":"Rev. Bras. Reumatol."},{"issue":"9","key":"10.1016\/j.steroids.2022.109063_b0100","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1089\/jwh.2017.6706","article-title":"Postmenopausal osteoporosis: a clinical review","volume":"27","author":"Watts","year":"2018","journal-title":"J. Womens Health (Larchmt.)"},{"issue":"1","key":"10.1016\/j.steroids.2022.109063_b0105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ecl.2016.09.009","article-title":"Drug-related adverse events of osteoporosis therapy","volume":"46","author":"Khan","year":"2017","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"1","key":"10.1016\/j.steroids.2022.109063_b0110","first-page":"126","article-title":"MicroRNA-221 is involved in the regulation of osteoporosis through regulates RUNX2 protein expression and osteoblast differentiation","volume":"9","author":"Zhang","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"4","key":"10.1016\/j.steroids.2022.109063_b0115","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/jbmr.3927","article-title":"PARP1 Hinders Histone H2B Occupancy at the NFATc1 Promoter to Restrain Osteoclast Differentiation","volume":"35","author":"Wang","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.steroids.2022.109063_b0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13075-016-1187-7","article-title":"Smad-dependent mechanisms of inflammatory bone destruction","volume":"18","author":"Fennen","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.steroids.2022.109063_b0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/ijms17030349","article-title":"MicroRNAs in osteoclastogenesis and function: potential therapeutic targets for osteoporosis","volume":"17","author":"Ji","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.steroids.2022.109063_b0130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13018-020-01688-5","article-title":"MiR-596 inhibits osteoblastic differentiation and cell proliferation by targeting Smad3 in steroid-induced osteonecrosis of femoral head","volume":"15","author":"Fu","year":"2020","journal-title":"J. Orthop. Surg. Res."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X22001015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X22001015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:09:19Z","timestamp":1758535759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X22001015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":26,"alternative-id":["S0039128X22001015"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2022.109063","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-221-5p\/Smad3 axis in osteoclastogenesis and its function: Potential therapeutic target for osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2022.109063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109063"}}